ROCKVILLE, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (NYSE Alternext US:RGN) announced today that J.J. Finkelstein, RegeneRx’s president and chief executive officer, will present a company update at the 22nd Annual Roth Capital Partners Growth Stock Conference in Laguna Nigel, CA. The presentation is scheduled for Wednesday, March 17, 2010 at 11:30 a.m. ET. To listen and view the webcast investors may either visit RegeneRx’s homepage at www.regenerx.com or click on the following link: http://www.wsw.com/webcast/roth23/rgn/ An archived copy of the presentation will be available on RegeneRx’s website.
